Evidence of nanobacterial-like structures in calcified human arteries and cardiac valves

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 3 56-3, 2004, Pages

  Miller, Virginia M ^a,d   Rodgers, George ^c   Charlesworth, Jon A ^b   Kirkland, Brenda ^c,e   Severson, Sandra R ^a   Rasmussen, Todd E ^a,f   Yagubyan, Marineh ^a   Rodgers, Jeri C ^c   Cockerill III, Franklin R ^a   Folk, Robert L ^c   Rzewuska Lech, Ewa ^a,g   Kumar, Vivek ^a   Farell Baril, Gerard ^a   Lieske, John C ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d MAYO CLINIC ROCHESTER   (United States)

^e UNIVERSITY OF MISSISSIPPI   (United States)

^f UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^g NONE   (Poland)

Author keywords

Aneurysm; Chlamydia; Infection; Inflammation; Nanobacteria

Indexed keywords

CALCIUM; CALCIUM PHOSPHATE; DNA; FLUORESCENT DYE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 8D10; NANOPARTICLE; PHOSPHORUS; UNCLASSIFIED DRUG; URIDINE;

ADULT; AGED; ANEURYSM; AORTA VALVE DISEASE; ARTERY CALCIFICATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; BACTERIUM; CAROTID ARTERY; CHLAMYDIA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; ELECTRON MICROSCOPY; FEMALE; FEMORAL ARTERY; GEOLOGY; HEART VALVE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFECTION; INFLAMMATION; ISOTOPE LABELING; MALE; NANOBACTERIUM; NEPHROLITHIASIS; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SPECTROSCOPY;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ARTERIES; BACTERIA; CALCINOSIS; CULTURE TECHNIQUES; FILTRATION; HEART VALVE DISEASES; HUMANS; MICROSCOPY, ELECTRON; MICROSCOPY, ELECTRON, SCANNING; MIDDLE AGED; NUCLEIC ACIDS; VASCULAR DISEASES;

EID: 4143105686     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00075.2004     Document Type: Article

References (52)

1. Akerman KK, Juronen I, and Kajander EO. Scanning electron microscopy of nanobacteria: novel biofilm producing organisms in blood. Scanning Electron Microscopy 15: 90-91, 1993.
2. Ameziane N, Beillat T, Verpillat P, Chollet-Martin S, Aumont MC, Seknadji P, Lamotte M, Lebret D, Ollivier V, and de Prost D. Association of the toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler Thromb Vasc Biol 23: e61-e64, 2003.
3. Bjorklund M, Ciftcioglu N, and Kajander EO. Extraordinary survival of nanobacteria under extreme conditions. SPIE 3441: 123-129, 1998.
4. Blacher J, Guerin AP, Pannier B, Marchais SJ, and London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38: 938-942, 2001.
5. Boyan BD, Schwartz Z, Swain LD, Carnes DL Jr, and Zislis T. Differential expression of phenotype by resting zone and growth region costochondral chondrocytes in vitro. Bone 9: 185-194, 1988.
6. Boyan BD, Schwartz ZVI, Carnes DL Jr, and Ramirez V. The effects of vitamin D metabolites on the plasma and matrix vesicle membranes of growth and resting cartilage cells in vitro. Endocrinology 122: 2851-2860, 1988.
7. Burke AP, Tracy RP, Kolodgie F, Malcolm GT, Zieske A, Kutys R, Pestaner J, Smialek J, and Virmani R. Elevated C-reactive protein values and atherosclerosis in sudden coronary death. Association with different pathologies. Circulation 105: 2019-2023, 2002.
8. Burnett MS, Gaydos CA, Madico GE, Glad SM, Paigen B, Quinn TC, and Epstein SE. Atherosclerosis in apoE knockout mice infected with multiple pathogens. J Infect Dis 183: 226-231, 2001.
9. Cifticioglu N and Kajander EO. Interaction of nanobacteria with cultured mammalian cells. Pathophysiology 4: 259-270, 1998.
10. Ciftcioglu N, Miller-Hjelle MA, Hjelle JT, and Kajander EO. Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method. Antimicrob Agents Chemother 46: 2077-2086, 2002.
11. Cisar JO, Xu DQ, Thompson J, Swaim W, Hu L, and Kopecko DJ. An alternative interpretation of nanobacteria-induced biomineralization. Proc Natl Acad Sci USA 97: 11511-11515, 2000.
12. Domingue GJ and Schlegel JU. Novel bacterial structures in human blood: cultural isolation. Infect Immun 15: 621-627, 1977.
13. Domingue GJ, Sr. and Woody HB. Bacterial persistence and expression of disease. Clin Microbiol Rev 10: 320-344, 1997.
14. Drancourt M, Jacomo V, Lepidi H, Lechevallier E, Grisoni V, Coulange C, Ragni E, Alasia C, Dussol B, Berland Y, and Raoult D. Attempted isolation of Nanobacterium sp. microorganisms from upper urinary tract stones. J Clin Microbiol 41: 368-372, 2003.
15. Engstrom G, Stavenow L, Hedblad B, Lind P, Tyden P, Janzon L, and Lindgarde F. Inflammation-sensitive plasma proteins and incidence of myocardial infarction in men with low cardiovascular risk. Arterioscler Thromb Vasc Biol 23: 2247-2251, 2003.
16. Epstein SE, Zhu J, Burnett MS, Zhou YF, Vercellotti GM, and Hajjar D. Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler Thromb Vasc Biol 20: 1417-1420, 2000.
17. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Rippin G, Victor A, Hafner G, Schlumberger W, and Meyer J. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 105: 15-21, 2002.
18. Folk RL. Bacteria and nannobacteria revealed in hardgrounds, calcite cements, native sulfur, sulfide minerals, and travertines. Geological Society of America Annual Meeting, Abstracts with Programs, 1992, vol. 24, p. 104.
19. Folk RL. SEM imaging of bacteria and nannobacteria in carbonate sediments and rocks. J Sed Petrol 63: 990-999, 1993.
20. Folk RL and Lynch FL. Organic matter, putative nannobacteria and the formation of ovoids and hardgrounds. Sedimentology 48: 215-229, 2001.
21. Folk RL and Lynch FL. The possible role of nannobacteria (dwarf bacteria) in clay-mineral diagenesis and the importance of careful sample preparation in high-magnification SEM study. J Sed Res 67: 583-589, 1997.
22. Gibbs RGJ, Carey N, and Davies AH. Chlamydia pneumoniae and vascular disease. Br J Surg 85: 1191-1197, 1998.
23. Greenland P, LaBree L, Azen SP, Doherty TM, and Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 291: 210-215, 2004.
24. Hjelle JT, Miller-Hjelle MA, Poxton IR, Kajander EO, Ciftcioglu N, Jones ML, Caughey RC, Brown R, Millikin PD, and Darras FS. Endotoxin and nanobacteria in polycystic kidney disease. Kidney Int 57: 2360-2374, 2000.
25. Hsu HHT and Camacho NP. Isolation of calcifiable vesicles from human atherosclerotic aortas. Atherosclerosis 143: 353-362, 1999.
26. Huber H, Hohn MJ, Rachel R, Fuchs T, Wimmer VC, and Stetter KO. A new phylum of Archaea represented by a nanosized hyperthermophilic symbiont. Nature 417: 63-67, 2002.
27. Jelic TM, Malas AM, Groves SS, Jin B, Mellen PF, Osborne G, Roque R, Rosencrance JG, and Chang HH. Nanobacteria-caused mitral valve calciphylaxis in a man with diabetic renal failure. South Med J 97: 194-198, 2004.
28. Kajander EO and Ciftcioglu N. Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc Natl Acad Sci USA 95: 8274-8279, 1998.
29. Kajander EO, Kuronen I, Akerman KK, Pelllari A, and Cifticioglu N. Nanobacteria from blood, the smallest culturable autonomously replicating agent on Earth. SPIE 3111: 420-428, 1997.
30. Kerr RA. Requiem for life on Mars? Support for microbes fades. Science 282: 1398-1400, 1998.
31. Kiechl S, Egger G, Mayr M, Wiedermann CJ, Bonora E, Oberhollenzer F, Muggeo M, Xu Q, Wick G, Poewe W, and Willeit J. Chronic infections and the risk of carotid atherosclerosis. Prospective results from a large population study. Circulation 103: 1064-1070, 2001.
32. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, Willeit J, and Schwartz DA. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347: 185-192, 2002.
33. Kim KM. Calcification of matrix vesicles in human aortic valve and aortic media. Fed Proc 35: 156-162, 1976.
34. Kim KM and Trump BF. Amorphous calcium precipitations in human aortic valve. Calcif Tissue Res 18: 155-160, 1975.
35. Kirkland BL, Lynch FL, Rahnis M, Folk RL, Molineux I, and McLean RJC. Alternative origins for nannobacteria-like objects in calcite. Geology 27: 347-350, 1999.
36. Kockx MA and Herman AG. Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc Res 45: 736-746, 2000.
37. Kockx MM, Muhring J, Bortier H, De Meyer GRY, and Jacob W. Biotin- or digoxigenin-conjugated nucleotides bind to matrix vesicles in atherosclerotic plaques. Am J Pathol 148: 1771-1777, 1996.
38. Maniloff J. Nannobacteria: size limits and evidence (Letter). Science 276: 1776-1777, 1997.
39. Martin GR, Schiffmann E, Bladen HA, and Nylen M. Chemical and morphological studies on the in vitro calcification of aorta. J Cell Biol 16: 243-252, 1963.
40. Nealson KH. Nannobacteria: size limits and evidence (Reply). Science 276: 1776-1777, 1997.
41. Pohle K, Maffert R, Ropers D, Moshage W, Stilianakis N, Daniel WG, and Achenbach S. Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors. Circulation 104: 1927-1932, 2001.
42. Prasad A, Zhu J, Halcox JPJ, Waclawiw MA, Epstein SE, and Quyyumi AA. Predisposition to atherosclerosis by infections. Role of endothelial dysfunction. Circulation 106: 184-190, 2002.
43. Rappe MS, Connon SA, Vergin KL, and Glovannoni SJ. Cultivation of the ubiquitous SAR11 marine bacterioplankton clade. Nature 418: 630-633, 2002.
44. Ross R and Glomset JA. The pathogenesis of atherosclerosis. N Engl J Med 295: 420-425, 1976.
45. Sedivy R and Battistutti WB. Nanobacteria promote crystallization of psammoma bodies in ovarian cancer. APMIS 111: 951-954, 2003.
46. Shioi A, Nishizawa Y, Jono S, Koyama H, Hosoi M, and Morii H. β-Glycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 15: 2003-2009, 1995.
47. Tintut Y and Demer LL. Recent advances in multifactorial regulation of vascular calcification. Curr Opin Lipidol 12: 555-560, 2001.
48. Tintut Y, Parhami F, Bostrom K, Jackson SM, and Demer LL. cAMP stimulates osteoblast-like differentiation of calcifying vascular cells. Potential signaling pathway for vascular calcification. J Biol Chem 273: 7547-7553, 1998.
49. Uwins PJR, Webb RI, and Taylor AP. Novel nano-organisms from Australian sandstones. Am Mineral 83: 1541-1550, 1998.
50. Vali H, McKee MD, Cifticioglu N, Sears K, Plows FL, Chevet E, Ghiabi P, Plavsic M, Kajander EO, and Zare RN. Nanoforms: a new type of protein-associated mineralization. Geochimica et Cosmochimica Acta 65: 63-74, 2001.
51. Vink A, Poppen J, Schoneveld AH, Roholl PJM, de Kleijn DPV, Borst C, and Pasterkamp G. Distribution of Chlamydia pneumoniae in the human arterial system and its relation to the local amount of atherosclerosis within the individual. Circulation 103: 1613-1617, 2001.
52. Wu LNY, Sauer GR, Genge BR, Valhmu WB, and Wuthier RE. Effects of analogues of inorganic phosphate and sodium ion on mineralization of matrix vesicles isolated from growth plate cartilage of normal rapidly growing chickens. J Inorg Biochem 94: 221-235, 2003.